Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
QDQuidelOrtho Corporation logo

QuidelOrtho Corporation (QDEL)

NASDAQ Global Select · Currency in USD
$13.73 ▲ +0.25 (+1.85%)
At close: Oct 23, 4:00 PM ET. Market closed.
$13.73 ▲ +0.00 (+0.00%)
After hours: Oct 23, 7:59 PM ET

Summary

Previous Close
$13.48
Open
$13.24
Day's Range
$12.45 – $13.80
52 Week Range
$9.92 – $35.58
Volume
1,407,413
Avg. Volume
1,679,977
Market Cap
$941.54M
Beta (5Y Monthly)
0.68
PE Ratio (TTM)
--
EPS (TTM)
-$15.35
Earnings Date
Nov 3, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$12.25

Profile: QuidelOrtho Corporation

Sector
Healthcare
Industry
Medical - Specialties
Full-time employees
6,500
CEO
Brian J. Blaser

QuidelOrtho Corporation specializes in the creation and production of diagnostic testing solutions, addressing a wide array of healthcare testing demands. The company operates through distinct business units. Its Labs division provides clinical chemistry and immunoassay instruments and tests designed to analyze bodily fluids and proteins, aiding in health assessment, patient management, and tracking disease progression.

Earnings

Next report: Tue, Nov 3, 2026
EPS estimate $0.20 · Revenue est. $627.83M
DateEst.Actual
Aug 6, 2026-$0.05$0.13Beat
May 5, 2026$0.37-$0.04Miss
Feb 11, 2026$0.43$0.46Beat
Nov 5, 2025$0.51$0.80Beat
Aug 5, 2025$0.00$0.12Beat
May 7, 2025$0.58$0.74Beat

Analyst view

Consensus price target
$12.25 ▼ -10.8%
Range $12.00 – $12.50
Rating: Hold
Buy 40% · Hold 47% · Sell 13%

Get free alerts on QDEL and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.